Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

OBJECTIVE: The cardiac safety of cetuximab and panitumumab, particularly as single agents, has not been investigated extensively. This trial was designed to specifically evaluate the cardiac safety of cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory metastatic colorecta...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xue-miao, Chen, Hao, Li, Qing, Song, Yiling, Zhang, Shuping, Xu, Xiao-Shuan, Xu, Yiwei, Chen, Shulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749385/
https://www.ncbi.nlm.nih.gov/pubmed/29343971
http://dx.doi.org/10.2147/OTT.S149716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749385/
https://www.ncbi.nlm.nih.gov/pubmed/29343971
http://dx.doi.org/10.2147/OTT.S149716

Ejemplares similares